🇩🇪 Germany Country × Condition
breast neoplasms Clinical Trials in Germany
Active clinical trials for breast neoplasms with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 4 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇩🇪 Germany
Active Trials in Germany (2)
NCT05573893
Recruiting
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
Enrollment
800 pts
Country
🇩🇪 Germany
AstraZeneca
View Trial → NCT05452213 Phase 4
Recruiting
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Enrollment
1,000 pts
Country
🇩🇪 Germany
Institut fuer Frauengesundheit
View Trial → Frequently Asked Questions
How many breast neoplasms clinical trials are active in Germany?
There are currently 2 active clinical trials for breast neoplasms with sites in Germany, of which 2 are actively recruiting patients.
How can I join a breast neoplasms clinical trial in Germany?
To join a breast neoplasms clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast neoplasms trials in Germany?
Active breast neoplasms trials in Germany span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.